-Similarly, if there is a flare up of hepatitis in case or HCV or HBV (ALT ≥ 500 U/L together with documented increased viral load), the addition of immunosuppressive therapy with close monitoring of LFTs, is strongly recommended, to lower the risk of evolution to fulminant hepatic failure REF). This evidence concerns the gene GPT and hepatitis A virus infection.